Crossmark

Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy

Crossref DOI link: https://doi.org/10.1186/s12944-019-1040-5

Published Online: 2019-04-04

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Michalczyk, Anna https://orcid.org/0000-0001-7433-161X
Dołęgowska, Barbara

Heryć, Rafał

Chlubek, Dariusz

Safranow, Krzysztof
License Information

Text and Data Mining valid from 2019-04-04
More Information

Article History

Received: 25 February 2019

Accepted: 29 March 2019

First Online: 4 April 2019

Ethics approval and consent to participate

: The study was approved by the Bioethical Commission of Pomeranian Medical University in Szczecin (study no. KB-0012/36/11 with addendum KB-0012/84/12, KB-0012/130/15 and KB-0012/162/12). Informed consent was obtained from all participants of the study.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.